Jyothy Labs Limited, a prominent player in India’s fast-moving consumer goods (FMCG) sector, has announced its audited financial results for the quarter and year ending 31 March 2026. The company reported a notable volume growth of 10.8% in Q4 FY26, alongside a 7.7% increase in revenue, amounting to ₹717 crore. However, the operating EBITDA margin was recorded at 13.5%, impacted by lower sales realisation and inflation in input prices.
The financial year 2026 was characterised by uneven demand and increased input costs, especially in the latter part of the year due to geopolitical developments in West Asia. Despite these challenges, Jyothy Labs achieved consistent volume growth throughout the year, aided by strategic grammage actions and a gradual recovery in consumption, particularly in the second half. The reduction in GST rates further stimulated demand, notably in the Personal Care segment from the third quarter onwards.
Rural demand remained stable for most of the year, while urban demand improved following GST rate adjustments. Organised channels, including Modern Trade, E-commerce, and Quick Commerce, continued to expand rapidly, increasing their share of sales.
For the full financial year FY26, Jyothy Labs reported a revenue of ₹2,944 crore, with a value growth of 3.5% and a volume growth of 6%. The operating EBITDA stood at ₹449.9 crore, with a margin of 15.3%, and the profit after tax was ₹333.2 crore. The company remains debt-free with a strong cash position, and net working capital improved during the year. The Board has recommended a final dividend of ₹3.5 per share for FY26.
In terms of segment performance, the Fabric Care segment saw a value growth of 14.4% and a volume growth of 17.8% in Q4 FY26, and 8.1% in value and 9.5% in volume for the full year. The Dishwashing segment recorded flat value growth but achieved a 5% volume growth in Q4 FY26, with a full-year decline of 1.3% in value and a 6% increase in volume. The Personal Care segment returned to growth with a 20.1% value increase and a 20.8% volume increase in Q4 FY26, while the Household Insecticides segment grew 3% in value for the quarter.
Ms. M. R. Jyothy, Chairperson and Managing Director of Jyothy Labs Limited, commented on the financial performance, highlighting the challenges faced in FY26 due to demand and cost pressures. She noted the improvement in the second half of the year, particularly in Q4, and expressed cautious optimism about the future, emphasising the company’s focus on driving growth and scaling recent launches.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).